1. HIV and AIDS
The management of HIV and AIDS is an ongoing challenge for Anglo companies operating in countries with a high burden of HIV disease
Strategy remains unchanged:
Strong line management leadership
Prevention through education, reproductive health, condoms
Voluntary counselling and testing (VCT)
the entry point for both prevention and treatment
Care, support and treatment for HIV +ve employees
Results focus
Community partnerships

2. HIV and AIDS data 2005 and 2006 Southern Africa
Number of employees
121,113
115,878
Best estimate of HIV prevalence
23%
21%
Estimated number of HIV positive employees
28,291
24,211
Number of employees who received VCT for HIV
37,982
73,570
Percentage VCT uptake
31%
63%
Number of HIV positive employees enrolled in HIV disease management programmes
8,315
11,403
Number of employees taking ART
3,034
4,598
% of estimated HIV positive employees taking ART
10.7%
19.0%
Includes AngloGold Ashanti, excludes De Beers

3. Voluntary Counselling and Testing
Our main strategic thrust is getting all employees to know their HIV status through VCT
Uptake of HIV testing
2003
<10%
2004
21%
2005
31%
2006
63%
Target for 2007 = 70%

4. Antiretroviral Therapy (ART)
4598 employees on ART at end December 2006
Although this is approx 20% of estimated HIV +ve population, we believe that about 30% are in need of treatment now
Further successful VCT drives will help us close the treatment gap
Those who start treatment before they get sick have much better treatment outcomes
Treatment started late (Advanced AIDS) Mortality 20%
Treatment started before the onset of AIDS Mortality 5%
Over 94% of employees on treatment carry out their normal work and live healthy productive lives
Ensuring meticulous adherence to the treatment regimens is the most important long-term issue

5. Economic impact
HIV/AIDS cost to companies would be 5% of payroll without access to ART
The estimated average cost to the Anglo Group of not having a worker on treatment is:
R 235, 500 (Range R65,000 – R300,000) (constant 2006 Rand)
US $31,824 (Range $8,783 - $40,540)
Cost of providing ART in the first year is R1,650 ($223) per patient per month
Costs reduce over time due to economies of scale and declining drug prices
The cost of ART is more than covered by reduction in absenteeism and reduced health care costs
Savings from reduction in absenteeism cover 20 – 60% of ART costs
Savings from reduced hospitalisation cover 45 – 70% of ART costs
Conversion to US $ at spot rate as on 8 March 2007
Work carried out by the Health Economics Unit, Aurum Institute for Health Research

6. Cost of HIV
Cost of HIV to the business (without ART) in 2006 would amount to just over 5% of payroll (Range = 0.1% - 6.7%)
Without ART this is predicted to continue to increase through 2015

7. Trends in cost of ART provision

8. Absenteeism patterns by CD4 count before and after commencement of ART
ART start

9. Table of average net cost / savings over 24 months on treatment
Cost per patient per month on treatment
Health care savings
Absenteeism savings
Net cost / savings per patient per month on treatment
Per month over 12 months
R 1670 $226
R 610 $82
R 875 $115
Cost R 185 $25
Per month over 18 months
R 1403 $190
R 670 $91
R 947 $128
Saving R 214 $29
Per month over 24 months
R 1256 $170
R 740 $100
R 979 $132
Saving R 463 $63
Shows the importance of patient retention as savings start to accrue between 12 and 18 months period on treatment
Note that these figures change as new patients reach these periods
on treatment and this table therefore represents a snap shot of trends
to the end of 2005
Conversion to US $ at spot rate as on 20 March 2007
Source: Economic impact assessment carried out by Ms D Muirhead, Aurum Institute for Health Research

10. HIV and AIDS Community Partnerships
Community programmes are designed to build capacity for comprehensive HIV and AIDS services in communities associated with our operations
In partnership with local government, NGO’s, trade unions and private health service providers
Business in the Community international award recognised Anglo American’s leading HIV/AIDS responses in the workplace and in the community
Anglo Community HIV and AIDS Partnership programme $4.7 million over 3 years – started in 2003
Presence across eight regions of South Africa
Focus on youth education, awareness and leadership
New initiatives being developed in rural health care delivery
Business training on HIV and AIDS in China
Community education and awareness in Brazil
Seeking to extend community based initiatives to cover all our global operations
Focus on youth and the vulnerability of young women and girls to HIV infection

11. Stop AIDS Now!
For any given workplace community, measured over one year
Target three zeroes:
ZERO new HIV infections
ZERO people get sick or die from AIDS
ZERO babies born HIV positive
on a foundation of
ZERO tolerance of discrimination; stigmatisation or any breach of the human rights framework